Kurma Partners is a Paris-based venture capital firm specializing in healthcare and biotechnology, investing from company creation through growth stages across Europe. The firm manages over €470 million and focuses on transforming academic scientific discoveries into biotech and medtech companies.
62% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $60.1M (across 24 rounds with reported amounts).
Portfolio
62
Fund Size
$252M
Top Stage
Series A
Last 12 Mo
9
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
94 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 TargED Biopharmaceuticals B.V. | Unknown | — | Jun 2026 |
 Laigo Bio | Seed | — | Mar 2026 |
 Alveus Therapeutics Inc | Series A | $37M | Feb 2026 |
| Alveus Therapeutics Inc | Series A | $160M | Jan 2026 |
 Hopia | Unknown | — | Jan 2026 |
| TargED Biopharmaceuticals B.V. | Series A | — | Dec 2025 |
| Laigo Bio | Seed | — | Dec 2025 |
 Damae Medical | Series B | — | Nov 2025 |
 Adcytherix | Series A | — | Oct 2025 |
 Step Pharma | Series C | — | Oct 2025 |
 NUCLIDIUM AG | Series B | $79M | Jul 2025 |
 Elkedonia | Seed | — | Jun 2025 |
 Nuevocor | Series B | $45M | May 2025 |
 Deepull | Series C | — | Apr 2025 |
| DDEEPULL DIAGNOSTICS, S.L. | Series C | — | Apr 2025 |
 Poppins | Unknown | — | Apr 2025 |
 Coave Therapeutics | Series A | $33M | Jan 2025 |
| NUCLIDIUM AG | Series B | — | Jan 2025 |
 Coave Therapeutics | Series A | $32M | Jan 2025 |
| Nuevocor | Series B | $45M | Jan 2025 |
 Spotlight Medical | Seed | — | Jul 2024 |
 Scirhom | Series A | — | Jul 2024 |
| MMemo Therapeutics AG | Series C | — | May 2024 |
 Vico Therapeutics | Series B | $60M | Jan 2024 |
| Scirhom | Seed | — | Jan 2024 |
Page 1 of 4
Top Co-Investors
Idinvest Partners24 shared
Bpifrance19 shared
Eurazeo19 shared
Andera Partners17 shared
EQT Life Sciences14 shared
Pontifax12 shared
OrbiMed11 shared
Idinvest11 shared
Ysios Capital10 shared
Novo Capital9 shared
Angelini Ventures8 shared
Illumina Ventures8 shared
Fund+8 shared
Sofinnova Partners8 shared
High-Tech Gründerfonds7 shared
Pureos Bioventures7 shared
UI Investissement7 shared
Columbus Venture Partners7 shared
Hadean Ventures6 shared
Last updated: 20 October 2026